SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease

SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease

Background: Urinary symptoms are common, disabling and generally unresponsive to treatment in Parkinson´s disease (PD). Safinamide is approved as an add-on therapy to levodopa to improve fluctuations. Methods: Retrospective analysis of electronic records of nondemented PD patients seen consecutively...

Full description

Bibliographic Details
Main Authors: Ana Gómez-López, Arantxa Sánchez-Sánchez, Elena Natera-Villalba, Victoria Ros-Castelló, Álvaro Beltrán-Corbellini, Samira Fanjul-Arbós, Isabel Pareés Moreno, José Luis López-Sendon Moreno, Juan Carlos Martínez Castrillo, Araceli Alonso-Canovas
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Brain Sciences
Subjects:
safinamide
urinary symptoms
Parkinson disease
nonmotor fluctuations
Online Access:https://www.mdpi.com/2076-3425/11/1/57

Internet

https://www.mdpi.com/2076-3425/11/1/57

Similar Items